Part of a flu vaccine package insert--note the warning re vasculitis and other collagen vascular diseases. This is an inactivated (dead) vaccine, like anthrax--the kind that causes no problems according to DOD scientists

[Guest guest]

Postvaccination neurological disorders have been reported following the

use of almost all biological products. Guillain-Barre

syndrome (GBS) has been very rarely reported in temporal

association with administration of influenza vaccines. In the 1976

swine influenza vaccination program, the US Public Health Advisory

Committee on Immunization Procedures found that GBS

occurred at an incidence of approximately 1 in 100,000 after

immunisation and that the death rate in this `series' was

approximately 1 in 2,000,000. Such an excess incidence of GBS was

not demonstrated in subsequent years when recipients of the

1978 or 1979 vaccines were studied. However, in 1998, ACIP reported

that a study of the 1992-93 and 1993-94 seasons found an

elevation in the overall relative risk for GBS which represents an

excess of an estimated one to two cases of GBS per million

persons vaccinated.

Very rarely cases of vasculitis, arthritis, lupus erythematosus

rash/ syndrome or polymyalgia rheumatica have been reported

following vaccination with inactivated influenza vaccine. However,

the causality has not been established.